Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment
Ioulia Vogiatzi(Brigham and Women's Hospital), Khalid Shah(Brigham and Women's Hospital)
Cited by 5
Related Papers
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
|Nature Communications|2020|159
Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors
|Biomedicine & Pharmacotherapy|2023|16
IL13Rα2‑ and EGFR‑targeted pseudomonas exotoxin potentiates the TRAIL‑mediated death of GBM cells
|International Journal of Molecular Medicine|2021|11
An inducible RIPK3-driven necroptotic system enhances cancer cell–based immunotherapy and ensures safety
|Journal of Clinical Investigation|2024|11